Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia

T. Akaba (Tokyo, Japan), M. Kondo (Tokyo, Japan), K. Hara (Tokyo, Japan), A. Kurokawa (Tokyo, Japan), K. Takeyama (Tokyo, Japan), E. Tagata (Tokyo, Japan)

Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Session: Immunopathological mechanisms of lung disease
Session type: Thematic Poster
Number: 4087
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Akaba (Tokyo, Japan), M. Kondo (Tokyo, Japan), K. Hara (Tokyo, Japan), A. Kurokawa (Tokyo, Japan), K. Takeyama (Tokyo, Japan), E. Tagata (Tokyo, Japan). Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia. 4087

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004


High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

Bronchoalveolar lavage amylase levels can be a biomarker of aspiration pneumonia.
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006

ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012


Assessment of inflammation in asthma with ECP, endobronchial biopsy, bronchoalveolar lavage and sputum eosinophilia
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004

The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004

Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012



Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007

Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003



The comparison of bronchoalveolar lavage (BAL) with mini-BAL in pneumonia developed in immunocompromised patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011